Cargando…
Gut Microbiota: A Novel Therapeutic Target for Parkinson’s Disease
Parkinson’s disease (PD) is the second most common neurodegenerative disease characterized by motor dysfunction. Growing evidence has demonstrated that gut dysbiosis is involved in the occurrence, development and progression of PD. Numerous clinical trials have identified the characteristics of the...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9263276/ https://www.ncbi.nlm.nih.gov/pubmed/35812394 http://dx.doi.org/10.3389/fimmu.2022.937555 |